3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Breast Neoplasms
695
Neoplasms
613
Prostatic Neoplasms
315
Lung Neoplasms
308
Colorectal Neoplasms
282
Carcinoma, Non-Small-Cell Lung
254
Pancreatic Neoplasms
178
Carcinoma, Hepatocellular
168
Stomach Neoplasms
139
Multiple Myeloma
127
Ovarian Neoplasms
120
Melanoma
118
Colonic Neoplasms
112
Brain Neoplasms
108
Hematologic Neoplasms
107
Head and Neck Neoplasms
106
Urinary Bladder Neoplasms
103
Leukemia, Myeloid, Acute
102
Esophageal Neoplasms
101
Disease
100
Uterine Cervical Neoplasms
89
Neoplasm Metastasis
89
Liver Neoplasms
88
Rectal Neoplasms
85
Lymphoma
84
Precursor Cell Lymphoblastic Leukemia-Lymphoma
83
Endometrial Neoplasms
76
Carcinoma, Renal Cell
73
Leukemia
63
Recurrence
62
Interventions
edoxaban
1
apixaban
1
Rivaroxaban
1
Heparin, Low-Molecular-Weight
1
Dabigatran
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Embolism
×
1 year
×
Clear all
NCT04618913
2026-05-26
VICTORIE
Pfizer
Active not recruiting
1 enrolled